In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, highlights first-time ...

A deep learning system can accurately detect vision-threatening diabetic retinopathy, demonstrating specialist-level diagnostic performance.

Diabetic patients with high myopia have a significantly lower choroidal vascularity index (CVI) than those with diabetic retinopathy (DR), according to research published in Frontiers in Cell and ...

Diabetic Retinopathy (DR) is one of the visual abnormality of diabetes which affects the retina. The disease gradually damages the retina and leads to blindness in future. Detection and classification ...

However, the role of GLP-1 analogs in diabetic retinopathy (DR), a common complication of diabetes mellitus (DM), remains controversial. Retinal ganglion cells (RGCs) are the only afferent neurons ...

The aim of this review is to provide a clinical update on diabetic retinopathy (DR) for the primary care physician. It should be noted, however, that diabetes can impact other sites within the eye ...

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.

Perfuse Therapeutics reveals promising Phase 2 trial results for PER-001, a potential treatment for glaucoma and diabetic ...

Ophthalmologist , Vitreoretinal Surgeon, talks about how diabetic retinopathy is caused in patients with diabetes as well as treatment and management strategies.

R2 – preproliferative retinopathy: R2 – moderate BDR: High risk: 47 – moderate severe NPDR: ... Diabetic retinopathy (DR) is an important contributor to the burden of vision impairment.

Objective To explore the risk factors of diabetic retinopathy (DR) and sight-threatening diabetic retinopathy (STDR) among Chinese patients with diabetes. Design, setting and participants A ...